MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges

Detalles Bibliográficos
Autores principales: Krishnaswami, Sriram, Austin, Daren, Della Pasqua, Oscar, Gastonguay, Marc R., Gobburu, Jogarao, van der Graaf, Piet H., Ouellet, Daniele, Tannenbaum, Stacey, Visser, Sandra A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
White Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158219/
https://www.ncbi.nlm.nih.gov/pubmed/31955417
http://dx.doi.org/10.1002/cpt.1788
_version_ 1783522496074481664
author Krishnaswami, Sriram
Austin, Daren
Della Pasqua, Oscar
Gastonguay, Marc R.
Gobburu, Jogarao
van der Graaf, Piet H.
Ouellet, Daniele
Tannenbaum, Stacey
Visser, Sandra A. G.
author_facet Krishnaswami, Sriram
Austin, Daren
Della Pasqua, Oscar
Gastonguay, Marc R.
Gobburu, Jogarao
van der Graaf, Piet H.
Ouellet, Daniele
Tannenbaum, Stacey
Visser, Sandra A. G.
author_sort Krishnaswami, Sriram
collection PubMed
description
format Online
Article
Text
id pubmed-7158219
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71582192020-04-20 MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges Krishnaswami, Sriram Austin, Daren Della Pasqua, Oscar Gastonguay, Marc R. Gobburu, Jogarao van der Graaf, Piet H. Ouellet, Daniele Tannenbaum, Stacey Visser, Sandra A. G. Clin Pharmacol Ther White Papers John Wiley and Sons Inc. 2020-02-20 2020-04 /pmc/articles/PMC7158219/ /pubmed/31955417 http://dx.doi.org/10.1002/cpt.1788 Text en © 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle White Papers
Krishnaswami, Sriram
Austin, Daren
Della Pasqua, Oscar
Gastonguay, Marc R.
Gobburu, Jogarao
van der Graaf, Piet H.
Ouellet, Daniele
Tannenbaum, Stacey
Visser, Sandra A. G.
MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges
title MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges
title_full MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges
title_fullStr MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges
title_full_unstemmed MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges
title_short MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges
title_sort mid3: mission impossible or model‐informed drug discovery and development? point‐counterpoint discussions on key challenges
topic White Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158219/
https://www.ncbi.nlm.nih.gov/pubmed/31955417
http://dx.doi.org/10.1002/cpt.1788
work_keys_str_mv AT krishnaswamisriram mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT austindaren mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT dellapasquaoscar mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT gastonguaymarcr mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT gobburujogarao mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT vandergraafpieth mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT ouelletdaniele mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT tannenbaumstacey mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges
AT vissersandraag mid3missionimpossibleormodelinformeddrugdiscoveryanddevelopmentpointcounterpointdiscussionsonkeychallenges

Ejemplares similares